Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome.
Type of Publication
Journal Article
Year of Publication
2017
Journal
Nephrology (Carlton)
DOI
10.1111/nep.12924
Language
Eng
ISSN Number
1440-1797
Volume
22
Issue
9
Number of Pages
731-732
Links to full text